These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6785785)

  • 21. A biochemical and morphological study of the altered growth pattern of central catecholamine neurons following 6-hydroxydopamine.
    Konkol RJ; Bendeich EG; Breese GR
    Brain Res; 1978 Jan; 140(1):125-35. PubMed ID: 626876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in spontaneous activity and emotional responses of rats treated with 6-hydroxydopamine at the suckling age.
    Fukuda T; Yamada K; Suenaga N; Takishita S
    Arch Int Pharmacodyn Ther; 1977 Nov; 230(1):100-11. PubMed ID: 603300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal sympathectomy by 6-hydroxydopamine in the rat: no effects on behavior by changes in endogenous brain norepinephrine.
    Pappas BA; Sobrian SK
    Life Sci I; 1972 Jul; 11(14):653-9. PubMed ID: 4656097
    [No Abstract]   [Full Text] [Related]  

  • 24. Behavioural effects of neonatal systemic 6-hydroxydopamine.
    Saari M; Pappas BA
    Neuropharmacology; 1978 Oct; 17(10):863-71. PubMed ID: 745682
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA).
    Lipton SV; McGough JP; Shaywitz BA
    Pharmacol Biochem Behav; 1980 Sep; 13(3):371-7. PubMed ID: 7191569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth, behavior, and brain catecholamines in lead-exposed neonatal rats: a reappraisal.
    Golter M; Michaelson IA
    Science; 1975 Jan; 187(4174):359-61. PubMed ID: 1167426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intraventricular injections of 6-hydroxydopamine in neonatal rats on the catecholamine levels and tyrosine hydroxylase activity in brain regions at maturity.
    Peters DA; Pappas BA; Taub H; Saari M
    Biochem Pharmacol; 1977 Dec; 26(23):2211-5. PubMed ID: 22332
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of 6-hydroxydopamine-induced catecholamine depletion on shock-precipitated wall climbing of infant rat pups.
    Emerich DF; Scalzo FM; Enters EK; Spear NE; Spear LP
    Dev Psychobiol; 1985 May; 18(3):215-27. PubMed ID: 3921418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catecholamines and serotonin in rat frontal cortex after PCPA and 6-OHDA: absolute amounts and ratios.
    Reader TA
    Brain Res Bull; 1982 May; 8(5):527-34. PubMed ID: 6214300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of neonatal and adult 6-hydroxydopamine treatment on random-interval behavior.
    Levine TE; Erinoff L; Dregits DP; Seiden LS
    Pharmacol Biochem Behav; 1980 Feb; 12(2):281-5. PubMed ID: 7375490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal 6-hydroxydopamine attenuates the neural and behavioral effects of enriched rearing in the rat.
    O'Shea L; Saari M; Pappas BA; Ings R; Stange K
    Eur J Pharmacol; 1983 Aug; 92(1-2):43-7. PubMed ID: 6414825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
    Olds ME; Yuwiler A
    Psychopharmacology (Berl); 1985; 87(4):484-9. PubMed ID: 3936107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behaviour and brain catecholamine metabolism.
    Laverty R; Taylor KM
    Br J Pharmacol; 1970 Dec; 40(4):836-46. PubMed ID: 5495179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-lasting peripheral and central effects of 6-hydroxydopamine in rats.
    Clark DW; Laverty R; Phelan EL
    Br J Pharmacol; 1972 Feb; 44(2):233-43. PubMed ID: 4677508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.
    Shaywitz BA; Lipton SV; Teicher MH; Cohen DJ; Anderson GM; Batter DK; Young JG
    Pharmacol Biochem Behav; 1981 Sep; 15(3):443-8. PubMed ID: 6794039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open-field behavior in dopamine-depleted rat pups and their mothers.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1983 Feb; 18(2):285-7. PubMed ID: 6403951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of neonatal 6-hydroxydopamine administration on the catecholaminergic structures of the hypothalamus and on the behavior of rats of various ages].
    Konstantinova MS; Semenova TP; Grishchenko NI; Gromova EA; Polenov AL
    Ontogenez; 1989; 20(3):332-6. PubMed ID: 2549482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.